Web Results

Vaso Active Pharmaceuticals, Inc., Debtors, Jeoffrey L. Burtch ...

www.deb.uscourts.gov/sites/default/files/opinions/judge-christopher-s.sontchi/opinion.8.11.14.pdf

Aug 11, 2014 ... FOR THE DISTRICT OF DELAWARE. In re: ) Chapter 11. ) VASO ACTIVE PHARMACEUTICALS, INC., ). ) Case No. 10-10855 (CSS). Debtors.

Vaso Active Pharmaceuticals, Inc. : Lit. Rel. No. 18834 / August 17 ...

www.sec.gov/litigation/litreleases/lr18834.htm

Aug 17, 2004 ... Litigation Release No. 18834 / August 17, 2004. SEC Files Settled Action Charging Vaso Active Pharmaceuticals, Inc. and its President and ...

Cases | A.B. Data Class Action Administration

www.abdataclassaction.com/cases/

Beverly Enterprises - Arkansas, Inc., et al. and Vera Cooney and Eula Mae Allen, et al., v. Beverly ...... In re Vaso Active Pharmaceuticals Securities Litigation.

VPAC1 receptor expression in peripheral blood mononuclear cells ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3651401/

May 7, 2013 ... Vasoactive intestinal peptide (VIP) exerts immune-modulatory actions mainly .... B according the protocol (Phoenix Pharmaceuticals Inc., Karlsruhe, Germany) and .... It is likely that receptor internalization as described by Langlet et al., [27] is ... As suggested previoulsy [27], recycling and re-organization of ....

Full Text (PDF)

www.pnas.org/content/106/27/11282.full.pdf

Jul 7, 2009 ... heart failure while lacking the vasoactive properties of BNP. These findings ... Genome-wide analyses have revealed the prevalence of al- ternative .... Pan et al . PNAS. July 7 ... As alternative splicing usually affects coding re- .... BNP (hBNP, Phoenix Pharmaceuticals, Inc.) or ASBNP.1 (final concentration.

A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of ...

journals.plos.org/plosone/article?id=10.1371/journal.pone.0107382

Sep 22, 2014 ... A vasoactive role for relaxin is supported by our recent data that .... ml TriReagent (Ambion Inc., Scoresbury, VIC, Australia) and total RNA was ..... This could have been due to differences in compositional remodeling or re-arrangement of .... 9. van Drongelen J, van Koppen A, Pertijs J, Gooi J, Parry L, et al.

Vasoactive Factors and Inflammatory Mediators Produced in ...

link.springer.com/chapter/10.1007/978-1-59745-370-7_5

Abstract. In the search for mechanisms of obesity-mediated vascular pathology, attention has been focused on the role played by adipose tissue, ...

Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3109075/

Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in Humans In Vivo .... Then, 0.5% albumin (albumin [human], U.S. Pharmacopeia; Plasbumin-25; Bayer, Pharmaceutical Division, Elkhart, IN) .... (SPSS 11.5 for Windows; SPSS Inc., Chicago, IL). ..... Takiyyuddin MA, Parmer RJ, Kailasam MT, et al.

Rhythmic Secretion of Prolactin in Rats: Action of Oxytocin ...

press.endocrine.org/doi/full/10.1210/en.2003-1710

Polyurethane catheter tubing (Micro-Renathane, Braintree Scientific Inc., ... was performed with the Phoenix OT kit (Phoenix Pharmaceuticals Inc., Belmont, CA, ... per animal for the intensity of VIP immunoreactivity as described by Turgeon et al. ..... Arey BJ, Freeman ME 1990 Oxytocin, vasoactive-intestinal peptide, and ...

Effect of vasoactive peptides in Tetrahymena: chemotactic activities ...

link.springer.com/article/10.1007/s11010-015-2589-6

You're seeing our new article page and we'd like your opinion, send feedback ... Cite this article as: Kőhidai, L., Tóth, K., Samotik, P. et al. .... Peptides tested were human adrenomedullin1-52, PAMP and CGRP (Phoenix Pharmaceuticals Inc.).

More Info

George L. Miller v. JNJ Logistics LLC - District of Delaware

www.deb.uscourts.gov

Aug 14, 2014 ... In Re: : : PROLIANCE INTERNATIONAL, INC., et al. : Chapter 7 ...... this ruling in In re Vaso Active Pharmaceuticals, Inc.43 Therein, the.

Vaso Active Pharmaceuticals, Inc.: OTCMKTS:VAPHQ quotes ...

www.google.com

Get detailed financial information on Vaso Active Pharmaceuticals, Inc. ( OTCMKTS:VAPHQ) including real-time stock quotes, historical charts & financial news, ...

New Value Does Not Need to Remain Unpaid. - Buchanan Ingersoll ...

www.bipc.com

Oct 29, 2014 ... In In re Proliance International, Inc., et al., Judge Sontchi of the United ... Design, Inc. and In re Vaso Active Pharmaceuticals, Inc., at lease by.